Does CABAZITAXEL Cause Deep vein thrombosis? 28 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Deep vein thrombosis have been filed in association with CABAZITAXEL (Jevtana). This represents 1.1% of all adverse event reports for CABAZITAXEL.
28
Reports of Deep vein thrombosis with CABAZITAXEL
1.1%
of all CABAZITAXEL reports
1
Deaths
10
Hospitalizations
How Dangerous Is Deep vein thrombosis From CABAZITAXEL?
Of the 28 reports, 1 (3.6%) resulted in death, 10 (35.7%) required hospitalization, and 3 (10.7%) were considered life-threatening.
Is Deep vein thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABAZITAXEL. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does CABAZITAXEL Cause?
Febrile neutropenia (197)
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Disease progression (143)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which CABAZITAXEL Alternatives Have Lower Deep vein thrombosis Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE